The largest database of trusted experimental protocols

Stabilizer free hsa

Manufactured by Merck Group
Sourced in United States

Stabilizer-free HSA is a high-purity human serum albumin product manufactured by Merck Group. It is designed to function as a stabilizer and preservative in a variety of cell culture and biopharmaceutical applications.

Automatically generated - may contain errors

2 protocols using stabilizer free hsa

1

Quantification of Caprylate in HSA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The quantification of caprylate was performed with a free fatty acid quantification assay kit (abcam, Cambridge, UK). This kit provides a sensitive, enzyme-based method for colorimetric detection of long- and middle chain free fatty acids in biological samples. Concentrations of free fatty acids in the samples were calculated from standards which are included in the kit. To obtain a signal in the standard range (0 to 200 μM), the samples were diluted 1:100 with dilution reagent which was provided with the kit. The amount of caprylate was calculated in percent of the untreated 20% HSA-solution (Kedrion Biopharmaceuticals, Italy), and as negative control the stabilizer-free HSA (Sigma Aldrich, USA) was used.
+ Open protocol
+ Expand
2

HPLC Quantification of N-Acetyltryptophanate

Check if the same lab product or an alternative is used in the 5 most similar protocols
The quantification of N-acetyltryptophanate was performed with a high performance liquid chromatography method. Samples were precipitated by adding 50 μl HSA sample to 250 μl methanol, vortexed, and cooled at -80°C for 20 minutes. After centrifugation (14000 g, 5 min) 20 μl of the supernatant was injected into the HPLC column (150 x 4.6 mm Nucleosil 100–5 C18 column combined with a 4 x 3 mm Nucleosil 100–5 C18 guard column; Macherey-Nagel, Düren, Germany). The temperature of the column oven was set to 35°C. The elution consisted of a linear gradient program from 30 to 50% methanol in water over 6.5 minutes, maintained at 50% methanol for 1 minute and returned to 30% methanol for 1 minute. The flow rate was 0.5 ml/min and absorbance detection at 280 nm was performed for NAT quantification. The amount of N-acetyltryptophanate was calculated in percent of the untreated 20% HSA-solution (Kedrion Biopharmaceuticals, Italy), and as negative control the stabilizer-free HSA (Sigma Aldrich, USA) was analyzed. The recovery of NTA using this HPLC procedure is 72.3 ± 0.5% (S1 Fig). It was determined by comparing the peak areas between NTA diluted in methanol and NTA spiked in stabilizer-free albumin solution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!